AVTR:NYE-Avantor, Inc (USD)

COMMON STOCK | Specialty Chemicals | NYE

Last Closing Price

USD 32.23

Change

+0.63 (+1.99)%

Market Cap

USD 18.55B

Volume

3.71M

Average Target Price

USD 31.88 (-1.10%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, and clinical trial kits. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-04-21 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
LIN Linde plc

+6.13 (+2.14%)

USD149.45B 60.71 19.97
SHW The Sherwin-Williams Company

+3.72 (+1.39%)

USD71.52B 36.31 23.63
ECL Ecolab Inc

+3.14 (+1.42%)

USD63.18B 53.50 30.58
PPG PPG Industries, Inc

+4.57 (+2.70%)

USD40.07B 33.71 20.18
IFF International Flavors & Fragra..

+2.04 (+1.44%)

USD35.29B 44.18 43.80
LYB LyondellBasell Industries N.V

+3.48 (+3.33%)

USD34.98B 24.66 15.43
ALB Albemarle Corporation

+4.53 (+3.05%)

USD17.33B 42.19 30.48
AVTR-PA Avantor, Inc

+69.13 (+218.77%)

USD16.39B 1,107.78 N/A
RPM RPM International Inc

+1.11 (+1.19%)

USD12.10B 26.69 16.97
WLK Westlake Chemical Corporation

+2.90 (+3.12%)

USD11.90B 36.28 11.95

ETFs Containing AVTR

Symbol Name Weight Mer Price(Change) Market Cap
BSJO Invesco BulletShares 2024.. 0.00 % 0.42 %

+0.03 (+0.12%)

USD0.29B
FHH:CA FT AlphaDEX U.S. Health C.. 0.00 % 0.70 %

+0.23 (+0.59%)

USD0.02B
IPO Renaissance IPO ETF 0.00 % 0.60 %

+0.59 (+0.95%)

USD0.68B
PYZ Invesco DWA Basic Materia.. 0.00 % 0.60 %

+2.12 (+2.62%)

USD0.14B
HYDW Xtrackers Low Beta High Y.. 0.00 % 0.20 %

+0.13 (+0.27%)

USD0.47B
SFYX SoFi Next 500 ETF 0.00 % 0.00 %

+0.12 (+0.88%)

USD0.02B

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.49% 59% F 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.49% 59% F 66% D
Trailing 12 Months  
Capital Gain 134.06% 72% C- 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 134.06% 72% C- 85% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 25.57% 92% A- 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.57% 92% A- 89% B+
Risk Return Profile  
Volatility (Standard Deviation) 40.26% 38% F 20% F
Risk Adjusted Return 63.51% 85% B 76% C
Market Capitalization 18.55B 85% B 88% B+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 354.22 5% F 2% F
Price/Book Ratio 11.21 8% F 9% F
Price / Cash Flow Ratio 19.95 27% F 22% F
EV/EBITDA 31.81 15% F 17% F
Management Effectiveness  
Return on Equity 4.54% 37% F 48% F
Return on Invested Capital 10.05% 66% D 76% C
Return on Assets 4.69% 68% D+ 78% C+
Debt to Equity Ratio 182.01% 35% F 19% F
Technical Ratios  
Short Ratio 4.33 18% F 15% F
Short Percent 5.88% 18% F 41% F
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.